Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Form 8.3 - DECHRA PHARMACEUTICALS PLC

11 Dec 2023 10:55

RNS Number : 3498W
Barclays PLC
11 December 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

08 Dec 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

1p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

7,569,260

6.65%

939,750

0.83%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

934,752

0.82%

7,507,163

6.59%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

8,504,012

7.47%

8,446,913

7.42%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

1p ordinary

Purchase

33,132

38.3315 GBP

1p ordinary

Purchase

8,924

38.3460 GBP

1p ordinary

Purchase

8,883

38.3180 GBP

1p ordinary

Purchase

7,303

38.3520 GBP

1p ordinary

Purchase

3,611

38.3544 GBP

1p ordinary

Purchase

1,798

38.3400 GBP

1p ordinary

Purchase

1,428

38.3212 GBP

1p ordinary

Purchase

1,408

38.3200 GBP

1p ordinary

Purchase

1,244

38.3583 GBP

1p ordinary

Purchase

661

38.3600 GBP

1p ordinary

Purchase

521

38.3500 GBP

1p ordinary

Purchase

6

38.3433 GBP

1p ordinary

Sale

83,153

38.3200 GBP

1p ordinary

Sale

13,157

38.3189 GBP

1p ordinary

Sale

13,051

38.3305 GBP

1p ordinary

Sale

7,491

38.3349 GBP

1p ordinary

Sale

4,386

38.3175 GBP

1p ordinary

Sale

3,477

38.3400 GBP

1p ordinary

Sale

1,345

38.3161 GBP

1p ordinary

Sale

1,119

38.3277 GBP

1p ordinary

Sale

517

38.3336 GBP

1p ordinary

Sale

514

38.3600 GBP

1p ordinary

Sale

308

38.3000 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

1p ordinary

SWAP

Closing Long

116

38.3400 GBP

1p ordinary

SWAP

Closing Long

7,622

38.3234 GBP

1p ordinary

SWAP

Closing Long

13,157

38.3189 GBP

1p ordinary

SWAP

Decreasing Long

13

38.3200 GBP

1p ordinary

SWAP

Decreasing Long

9,722

38.3285 GBP

1p ordinary

CFD

Decreasing Short

414

38.3124 GBP

1p ordinary

CFD

Decreasing Short

517

38.3336 GBP

1p ordinary

SWAP

Decreasing Short

585

38.3297 GBP

1p ordinary

CFD

Decreasing Short

634

38.3317 GBP

1p ordinary

SWAP

Decreasing Short

1,345

38.3161 GBP

1p ordinary

CFD

Decreasing Short

1,388

38.3508 GBP

1p ordinary

SWAP

Decreasing Short

2,342

38.3240 GBP

1p ordinary

CFD

Decreasing Short

5,625

38.3348 GBP

1p ordinary

SWAP

Decreasing Short

6,906

38.3353 GBP

1p ordinary

SWAP

Decreasing Short

72,489

38.3200 GBP

1p ordinary

SWAP

Increasing Short

6

38.3438 GBP

1p ordinary

CFD

Increasing Short

408

38.3600 GBP

1p ordinary

SWAP

Increasing Short

8,924

38.3460 GBP

1p ordinary

SWAP

Opening Short

11

38.3254 GBP

1p ordinary

SWAP

Opening Short

164

38.3400 GBP

1p ordinary

SWAP

Opening Short

16,527

38.3451 GBP

1p ordinary

SWAP

Opening Short

18,633

38.3346 GBP

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

11 Dec 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETEAEAFFSADFFA
Date   Source Headline
18th Dec 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 20233:20 pmRNSForm 8.3 -Dechra Pharmaceuticals plc
18th Dec 20232:57 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
18th Dec 20232:39 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
18th Dec 20232:39 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 20232:29 pmRNSHolding(s) in Company
18th Dec 20232:06 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 20231:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 20231:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 202311:59 amRNSForm 8.5 (EPT/RI)- Dechra Pharmaceuticals plc
18th Dec 202311:57 amRNSForm 8.5 (EPT/RI)- Dechra Pharmaceuticals plc
18th Dec 202311:25 amRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 202310:52 amRNSForm 8.5 (EPT/RI)
18th Dec 202310:49 amRNSForm 8.5 (EPT/NON-RI)
18th Dec 20239:07 amRNSHolding(s) in Company
18th Dec 20238:59 amRNSForm 8.3 - Dechra Pharmaceuticals plc
18th Dec 20238:27 amRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC Amend
18th Dec 20237:53 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
18th Dec 20237:00 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20233:30 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20233:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20233:30 pmRNSForm 8.3 - DPH LN
15th Dec 20233:20 pmRNSForm 8.3 -Dechra Pharmaceuticals plc
15th Dec 20232:43 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20232:30 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20232:00 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 20231:48 pmRNSHolding(s) in Company
15th Dec 20231:47 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Dec 20231:30 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Dec 202312:40 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Dec 202312:09 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
15th Dec 202311:57 amRNSHolding(s) in Company
15th Dec 202311:28 amRNSForm 8.5 (EPT/RI)- Dechra Pharmaceuticals plc
15th Dec 202310:34 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Dec 202310:17 amRNSForm 8.5 (EPT/RI)
15th Dec 202310:16 amRNSForm 8.5 (EPT/NON-RI)
15th Dec 20239:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Dec 20233:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Dec 20233:10 pmRNSForm 8.3 - Dechra Pharmaceuticals
14th Dec 20233:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Dec 20232:13 pmRNSForm 8.3 - DECHRA PHARMACEUTICALS PLC
14th Dec 20232:07 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
14th Dec 20231:56 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
14th Dec 20231:35 pmRNSHolding(s) in Company
14th Dec 20231:35 pmRNSHolding(s) in Company
14th Dec 20231:01 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Dec 202312:30 pmRNSDirector Declaration
14th Dec 202312:23 pmRNSHolding(s) in Company
14th Dec 202311:39 amRNSForm 8.3 - Dechra Pharmaceuticals plc
14th Dec 202311:30 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.